Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | LTB4R | Q15722 | 7/20 | 0.48 |
| ▸ | TBXAS1 | P24557 | 6/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7045028 | 0.98 | MAPT (0.59) | MAPTRXFP1NAAAHDAC3MAPK1 | |
| SCHEMBL28150240 | 0.98 | MAPT (0.59) | MAPTRXFP1NAAAHDAC3MAPK1 | |
| SCHEMBL709035 | 0.98 | MAPT (0.59) | MAPTRXFP1NAAAHDAC3MAPK1 | |
| SCHEMBL600268 | 0.94 | SMN1; SMN2 (0.57) | MAPTRXFP1NAAAHDAC3MAPK1 | |
| SCHEMBL599876 | 0.86 | KEAP1 (0.54) | NAAATAAR1 | |
| SCHEMBL28304375 | 0.85 | NAAA (0.52) | MAPTRXFP1NAAASMN1; SMN2HDAC8 | |
| Hydrochloric Acid SCHEMBL27428710 | 0.85 | KEAP1 (0.52) | NAAATAAR1 | |
| SCHEMBL934620 | 0.84 | NAAA (0.55) | MAPTRXFP1NAAAHDAC1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27525503 | 0.84 | NAAA (0.51) | MAPTRXFP1NAAASMN1; SMN2HDAC8 | |
| SCHEMBL19612574 | 0.82 | NAAA (0.53) | MAPTRXFP1NAAAHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234259-A | Perovskite solar cell, preparation method and application thereof | 长三角太阳能光伏技术创新中心 | 2024-06-21 | — | — | CN | claimed |
| CN-117529120-A | Perovskite solar cell, laminated solar cell and manufacturing method | 隆基绿能科技股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-120826094-B | Photovoltaic cell, preparation method thereof and photovoltaic module | 晶科能源(海宁)有限公司 | 2026-02-24 | — | — | CN | disclosed |
| CN-120826094-A | Photovoltaic cell, preparation method thereof and photovoltaic module | 晶科能源(海宁)有限公司 | 2025-10-21 | — | — | CN | disclosed |
| CN-118234259-A | Perovskite solar cell, preparation method and application thereof | 长三角太阳能光伏技术创新中心 | 2024-06-21 | — | — | CN | disclosed |
| US-9181196-B2 | Pharmaceutical compounds | KEMOTECH S.R.L. (IT) | 2015-11-10 | — | — | US | disclosed |
| EP-2678328-B1 | NOVEL CARBOXAMIDE MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-01-21 | — | — | EP | disclosed |
| US-20140343294-A1 | PHARMACEUTICAL COMPOUNDS | KEMOTECH S.R.L. (IT) | 2014-11-20 | — | — | US | disclosed |
| US-20140343294-A1 | PHARMACEUTICAL COMPOUNDS | KEMOTECH S.R.L. (IT) | 2014-11-20 | — | — | US | disclosed |
| US-20140343294-A1 | PHARMACEUTICAL COMPOUNDS | KEMOTECH S.R.L. (IT) | 2014-11-20 | — | — | US | disclosed |
| EP-2789619-A1 | Pharmaceutical compounds wiht angiogenesis inbhibitory activity | Kemotech S.r.l. (IT) | 2014-10-15 | — | — | EP | disclosed |
| US-8822523-B2 | Carboxamide microbiocides | SYNGENTA PARTICIPATIONS AG (CH) | 2014-09-02 | — | — | US | disclosed |
| US-8822523-B2 | Carboxamide microbiocides | SYNGENTA PARTICIPATIONS AG (CH) | 2014-09-02 | — | — | US | disclosed |
| US-20140031405-A1 | NOVEL CARBOXAMIDE MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-01-30 | — | — | US | disclosed |
| US-20140031405-A1 | NOVEL CARBOXAMIDE MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-01-30 | — | — | US | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343294-A1 | PHARMACEUTICAL COMPOUNDS | CYP3A43, CYP2D6, CYP2C9 | MAPT 2021/4885RXFP1 1797/4885NAAA 2027/4885 |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | MAPT 2214/4885RXFP1 4843/4885NAAA 704/4885 |
| US-20140031405-A1 | NOVEL CARBOXAMIDE MICROBIOCIDES | C3AR1, C5AR1, MSR1 | MAPT 2185/4885RXFP1 1012/4885NAAA 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.